Start Date
Immediate
Expiry Date
11 Dec, 25
Salary
0.0
Posted On
12 Sep, 25
Experience
0 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Market Access, Communication Skills, Project Management Software, Biostatistics, Health Economics, Pharmaceutical Industry, Clinical Development, Life Sciences
Industry
Pharmaceuticals
EU HTA Project Manager - International HTA Strategy
Maidenhead, England
Job ID: R00133445
Company Description
AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio.
Job Description
Advances in scientific and technological research are opening up new, promising treatments for previously difficult to treat diseases, increasing the demand on already constrained healthcare budgets. The challenging economic and political environment is leading Health Technology Assessment (HTA) agencies and payers to demand better outcomes at lower cost to overall health system.
In 2021 European commission adopted the EU HTA regulation with the key objectives of accelerating patient access to innovative treatments by harmonizing methodologies, establishing predictability and avoiding duplications. For AbbVie, this provides a unique opportunity to demonstrate the value attributes of our assets & strengthen affiliate position in country P&R appraisals. Joint Clinical Assessments is the key component of the EU HTA regulation and comprises the EU HTA dossier that will need to be submitted to the Member State Coordination Group on HTA; eg, to address issues of relative effectiveness and relative safety within a single submission. For AbbVie, JCA will enable better planning of market access strategies across Europe, driving the perception of value, removing redundancies with repetitive dossiers, saving time and ultimately resulting in smoother P&R negotiations, aiming to achieve faster and broader access for patients.
To succeed in this environment, we (AbbVie) need to fully understand market value drivers, identify the evidence required for Pricing, Reimbursement and Access (PRA), and work with the evidence generating functions to ensure that evidence generated will support successful Joint Clinical Assessments (JCA) and HTA outcome along with PRA negotiations.
The International HTA Strategy team was established to realize the full value of our assets by strategically informing drug development, evidence generation and HTA submissions, aligned with HTA/payer needs. The primary goals of the function are to ensure HTA evidence requirements are considered early in the development of Abbvie assets and a robust and aligned HTA strategy including EUHTA across the organization in order to ensure the successful launch of Abbvie assets. The International HTA Strategy team oversees EU HTA Regulation implementation for AbbVie and leads JSC and JCA strategy development and execution.
As a EUHTA Project Manager, you will ensure the Joint Clinical Assessment cross-functional teams successfully deliver projects within scope, on time, and within budget. You will ensure that project objectives are achieved while adhering to quality and regulatory standards.
WHAT WE OFFER YOU:
Qualifications and Experience
Qualifications and Experience
Key Behaviors
Persistent and resilient —finds the way to move good ideas forward